Chapter4 2 4. An Overview of PET Radiopharmaceuticals in Clinical Use: Regulatory, Quality and Pharmacopeia Monographs of the United States and Europe Addendum - An Overview of PET Radiopharmaceuticals in Clinical Use: Regulatory, Quality and Pharmacopeia

Abstract Since 1976, more and more PET radiopharmaceuticals have been developed as the clinical introduction of [18F]FDG for various medical applications. However, few of them could be involved in routinely clinical use in hospitals partly because of restrictions in regulatory and facilities. This chapter aims to provide an overview of PET radiopharmaceuticals that are common manufactured (or prepared) in industry (or hospitals) about regulatory and quality aspects, and further summarize pharmacopeia-listed PET radiopharmaceuticals and their clinical usefulness herein. Particularly, PET radiopharmaceuticals listed in latest United States Pharmacopeia (USP) and/or European Pharmacopeia (EP) are included for this chapter. Finally, this chapter would be helpful in the basic understanding of clinical PET radiopharmaceuticals for physicians or technologists.